(Q37807282)

English

Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Olaf H. Drummer

3

0 references

Dimitri Gerostamoulos

object named as

D Gerostamoulos

2

0 references

author name string

J L Pilgrim

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

publication date

4 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Forensic Science Medicine and Pathology

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

162-184

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Adverse drug events and medication errors in Australia

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Pharmacogenomics--drug disposition, drug targets, and side effects

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Pharmacogenetics, adverse drug reactions and public health

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Inheritance and drug response

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Symbiotic relationship of pharmacogenetics and drugs of abuse.

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Pharmacogenetics of drugs of abuse

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Genetic variation in human disease and a new role for copy number variants

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Pharmacogenetics, drug-metabolizing enzymes, and clinical practice

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Adverse drug reactions and the elderly

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Pharmacogenetics and adverse drug reactions

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Cytochrome P450s and other enzymes in drug metabolism and toxicity

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Incidence of fatal adverse drug reactions: a population based study

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Cytochromes P450 and metabolism of xenobiotics

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Pharmacogenetics of the cytochromes P450.

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Metabolic polymorphisms

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Assessment of CYP1A2 activity in clinical practice: why, how, and when?

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Pharmacogenetics of cytochrome p4502D6: genetic background and clinical implication

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Genetic polymorphisms of cytochrome P450 enzymes and the effect on interindividual, pharmacokinetic variability in extensive metabolizers

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Effect of the CYP2C19 oxidation polymorphism on fluoxetine metabolism in Chinese healthy subjects

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19.

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Pharmacokinetics of citalopram in relation to genetic polymorphism of CYP2C19.

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

The CYP2C19 genotype and the use of oral contraceptives influence the pharmacokinetics of carisoprodol in healthy human subjects

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

CYP3A4 polymorphisms - potential risk factors for breast and prostate cancer: a huge review

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Cytochrome P450 3A and their regulation

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Grapefruit juice-drug interactions

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Genetic contribution to variable human CYP3A-mediated metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Actual and potential drug interactions associated with methadone

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Metabolic drug interactions with new psychotropic agents.

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

The serotonin syndrome, triptans, and the potential for drug-drug interactions

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Serotonin syndrome and other serotonergic disorders

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Selective serotonin reuptake inhibitor-induced serotonin syndrome: review

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

The Serotonin Syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Postmortem toxicology of drugs of abuse

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Ecstasy and the concomitant use of pharmaceuticals.

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Selective serotonin reuptake inhibitors. Pharmacology and clinical implications in anaesthesia and critical care medicine

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Fluoxetine metabolism and pharmacological interactions: the role of cytochrome p450

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Pharmacokinetics of selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Escitalopram for treatment of major depressive disorder in adults

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Stereochemistry and drug efficacy and development: relevance of chirality to antidepressant and antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Interpreting results of ethanol analysis in postmortem specimens: a review of the literature

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Tolerability and safety of fluvoxamine and other antidepressants

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Stereoisomers in Psychiatry: The Case of Escitalopram

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and Caucasians

2 references

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetics of the monoamine oxidase-A inhibitor moclobemide

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Death following acute poisoning by moclobemide.

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Clinical pharmacology of MAO inhibitors: safety and future

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Selegiline metabolism and cytochrome P450 enzymes: in vitro study in human liver microsomes

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Metabolism and pharmacokinetics of dothiepin

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Fatal intoxication due to dothiepin.

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Tricyclic antidepressant pharmacology and therapeutic drug interactions updated

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

The N-demethylation of the doxepin isomers is mainly catalyzed by the polymorphic CYP2C19.

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Venlafaxine: a 2003 update

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Cytochrome P450 2D6 genotype variation and venlafaxine dosage

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Role of CYP2D6 in the stereoselective disposition of venlafaxine in humans

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

St. John's wort and antidepressant drug interactions in the elderly

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.).

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Possible serotonin syndrome after combination of buspirone and St John's Wort

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Herb-drug interactions

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Illegal or legitimate use? Precursor compounds to amphetamine and methamphetamine

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Reduced (+/-)-3,4-methylenedioxymethamphetamine ("Ecstasy") metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro.

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Non-linear pharmacokinetics of MDMA ('ecstasy') in humans

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Ecstasy: pharmacodynamic and pharmacokinetic interactions

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Effect of methamphetamine on cytochrome P450 activity

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Concentrations and ratios of amphetamine, methamphetamine, MDA, MDMA, and MDEA enantiomers determined in plasma samples from clinical toxicology and driving under the influence of drugs cases by GC-NICI-MS.

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Experimental and Clinical Pharmacology: Opioids - mechanisms of action

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

The experimental toxicology of tramadol: an overview

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Clinical pharmacology of tramadol

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Opioid metabolites

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Drug interactions with the potential to prevent prodrug activation as a common source of irrational prescribing in hospital inpatients

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Paroxetine, a cytochrome P450 2D6 inhibitor, diminishes the stereoselective O-demethylation and reduces the hypoalgesic effect of tramadol

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Post-mortem SNP analysis of CYP2D6 gene reveals correlation between genotype and opioid drug (tramadol) metabolite ratios in blood

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Tramadol as a new probe for cytochrome P450 2D6 phenotyping: a population study

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizers

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone.

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

CYP2D6 and CYP2C19 genotypes and amitriptyline metabolite ratios in a series of medicolegal autopsies

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Functional characterization of four allelic variants of human cytochrome P450 1A2.

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Fatality due to ingestion of tramadol alone

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

A fatal case of serotonin syndrome after combined moclobemide-citalopram intoxication

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

A fatal case of moclobemide-citalopram intoxication

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Involvement of amphetamines in sudden and unexpected death

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Death following ingestion of MDMA (ecstasy) and moclobemide

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Serotonin syndrome produced by a combination of fluoxetine and lithium

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Toxic reaction following the combined administration of fluoxetine and phenytoin: two case reports

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

An interaction between carbamazepine and fluvoxamine

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Serotonin syndrome with tramadol and citalopram

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Interaction of serotonergic antidepressants and opioid analgesics: Is serotonin syndrome going undetected?

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Serotonin syndrome induced by fluvoxamine and oxycodone

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Lethal combination of tramadol and multiple drugs affecting serotonin

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

A case of serotonin syndrome and mutism associated with methadone

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Interaction of methadone with substrates of human hepatic cytochrome P450 3A4.

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

The effect of sertraline on methadone plasma levels in methadone-maintenance patients

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Venlafaxine- and trazodone-induced serotonin syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Serotonin syndrome caused by selective serotonin reuptake-inhibitors-metoclopramide interaction

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Serotonin syndrome induced by a combination of bupropion and SSRIs

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamine.

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Drug interactions between linezolid and selective serotonin reuptake inhibitors: case report involving sertraline and review of the literature

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Interaction between pethidine and selegiline

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Severe adverse interaction between pethidine and selegiline

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Comparative pharmacology of dothiepin, its metabolites, and other antidepressant drugs

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Serotonin syndrome induced by fluvoxamine-lithium interaction

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Cytochrome P450 2D6 (CYP2D6) genotyping on postmortem blood as a supplementary tool for interpretation of forensic toxicological results

1 reference

https://api.crossref.org/works/10.1007%2FS12024-010-9188-3

21 January 2018

Role of cytochrome P450 2D6 (CYP2D6) in the stereospecific metabolism of E- and Z-doxepin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chirality and drugs used to treat psychiatric disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxic serotonin syndrome after fluoxetine plus carbamazepine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The CYP3A4*3 allele: is it really rare?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluvoxamine-tricyclic antidepressant interaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tramadol--present and future

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tramadol: a new centrally acting analgesic

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The serotonin syndrome. Fatal course of intoxication with citalopram and moclobemide]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human cytochrome P450 maximal activities in pediatric versus adult liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dothiepin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serotonin syndrome attributed to tramadol addition to paroxetine therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serotonin syndrome produced by paroxetine and low-dose trazodone

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serotonin toxicity with therapeutic doses of dexamphetamine and venlafaxine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Morphine-fluoxetine interactions in healthy volunteers: analgesia and side effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The serotonin syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trazodone is metabolized to m-chlorophenylpiperazine by CYP3A4 from human sources

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined SSRI-moclobemide treatment of psychiatric illness.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serotonin syndrome resulting from drug interactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is it safe to combine a selective serotonin reuptake inhibitor with selegiline?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

N-demethylation of amitriptyline in vitro: role of cytochrome P-450 3A (CYP3A) isoforms and effect of metabolic inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are metabolites of l-deprenyl (selegiline) useful or harmful? Indications from preclinical research

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of tramadol enantiomers and their respective phase I metabolites in relation to CYP2D6 phenotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serotonin syndrome - 'potential' role of the CYP2D6 genetic polymorphism in Asians.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluvoxamine and lithium: an unusual interaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytochrome P450 3A pharmacogenetics: the road that needs traveled

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stereospecific high-performance liquid chromatographic analysis of tramadol and its O-demethylated (M1) and N,O-demethylated (M5) metabolites in human plasma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidepressants: pharmacological profile and clinical consequences

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Possible serotonin syndrome associated with tramadol and sertraline coadministration

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential fluoxetine-selegiline interaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selegiline transdermal system: an examination of the potential for CYP450-dependent pharmacokinetic interactions with 3 psychotropic medications

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Possible toxicity of combined fluoxetine and lithium

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxic reaction following the combined administration of fluoxetine and L-tryptophan: five case reports

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comment on: the serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of human cytochrome P450 enzymes involved in the major metabolic pathway of fluvoxamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine).

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Citalopram--a review of pharmacological and clinical effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Possible serotonin syndrome with moclobemide and pethidine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stereoselective analyses of selegiline metabolites: possible urinary markers for selegiline therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug interactions in palliative care

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of trazodone metabolism by thioridazine in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Venlafaxine-lithium toxicity: suitability for use in the elderly

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Five novel natural allelic variants-951A>C, 1042G>A (D348N), 1156A>T (I386F), 1217G>A (C406Y) and 1291C>T (C431Y)-of the human CYP1A2 gene in a French Caucasian population

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stereospecific analysis and enantiomeric disposition of 3, 4-methylenedioxymethamphetamine (Ecstasy) in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methamphetamine and the expanding complications of amphetamines

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serotonin syndrome: report of a fatal case and review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serotonin syndrome with fluoxetine plus tramadol

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-competitive inhibition of clomipramine N-demethylation by fluvoxamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stereoselective in vivo and in vitro studies on the metabolism of doxepin and N-desmethyldoxepin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of fluoxetine and selegiline

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacogenetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The metabolism of tramadol by human liver microsomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacology of opioids. Part 2. Clinical aspects

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A case of severe lithium toxicity induced by combined fluoxetine and lithium carbonate

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship between imipramine metabolism and the sparteine oxidation polymorphism

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Six Patterns of Drug-Drug Interactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methylenedioxymethamphetamine (MDMA, "Ecstasy")

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse consequences of fluoxetine-MAOI combination therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolism of selegiline in humans. Identification, excretion, and stereochemistry of urine metabolites

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12024-010-9188-3

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37807282&oldid=2200968251"